NAALAD2 and hepatocellular carcinoma: Nomogram provided the graphical risk calculation for the 1-, 3-, and 5- year OS of HCC patients, using the independent expressions of ASPA, GOT2, NAALAD2 and SLC25A12 gene (Fig. 7C).